Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
United States Department of Veterans Affairs | 11 | 2015 | 875 | 1.000 |
Why?
|
Medicare | 25 | 2014 | 6566 | 0.530 |
Why?
|
Fee-for-Service Plans | 8 | 2014 | 694 | 0.520 |
Why?
|
Healthcare Disparities | 5 | 2014 | 3154 | 0.500 |
Why?
|
Quality of Health Care | 15 | 2015 | 4369 | 0.470 |
Why?
|
Hospitals, Veterans | 7 | 2015 | 404 | 0.440 |
Why?
|
SEER Program | 18 | 2014 | 1507 | 0.440 |
Why?
|
Colorectal Neoplasms | 13 | 2015 | 6773 | 0.420 |
Why?
|
Skin Diseases, Infectious | 1 | 2012 | 74 | 0.410 |
Why?
|
Soft Tissue Infections | 1 | 2012 | 155 | 0.370 |
Why?
|
Veterans | 3 | 2012 | 2519 | 0.350 |
Why?
|
Lung Neoplasms | 19 | 2015 | 13104 | 0.350 |
Why?
|
Reimbursement, Incentive | 3 | 2012 | 540 | 0.350 |
Why?
|
Quality Indicators, Health Care | 13 | 2015 | 1831 | 0.320 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2015 | 5223 | 0.320 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.310 |
Why?
|
Guideline Adherence | 8 | 2012 | 2265 | 0.310 |
Why?
|
Pneumonectomy | 2 | 2011 | 1094 | 0.310 |
Why?
|
Propensity Score | 3 | 2013 | 1781 | 0.300 |
Why?
|
Minority Groups | 3 | 2012 | 1221 | 0.300 |
Why?
|
Coronary Angiography | 9 | 2004 | 4576 | 0.280 |
Why?
|
Myocardial Infarction | 17 | 2010 | 11718 | 0.280 |
Why?
|
Bayes Theorem | 3 | 2014 | 2307 | 0.270 |
Why?
|
Cluster Analysis | 1 | 2013 | 2715 | 0.270 |
Why?
|
United States | 53 | 2015 | 69872 | 0.270 |
Why?
|
Rectal Neoplasms | 2 | 2012 | 1205 | 0.260 |
Why?
|
Models, Statistical | 7 | 2014 | 5101 | 0.240 |
Why?
|
Health Services Misuse | 4 | 2014 | 243 | 0.230 |
Why?
|
Neoplasms | 16 | 2015 | 21696 | 0.230 |
Why?
|
Health Expenditures | 4 | 2013 | 2349 | 0.230 |
Why?
|
Antimanic Agents | 1 | 2007 | 522 | 0.230 |
Why?
|
Colonic Neoplasms | 3 | 2011 | 2542 | 0.220 |
Why?
|
Small-Area Analysis | 3 | 2014 | 55 | 0.220 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1714 | 0.210 |
Why?
|
Managed Care Programs | 6 | 2007 | 950 | 0.210 |
Why?
|
Breast Neoplasms | 15 | 2014 | 20824 | 0.210 |
Why?
|
Aged, 80 and over | 36 | 2015 | 57776 | 0.200 |
Why?
|
Hospice Care | 6 | 2011 | 672 | 0.190 |
Why?
|
Cost of Illness | 2 | 2008 | 1860 | 0.180 |
Why?
|
Aged | 59 | 2015 | 163288 | 0.180 |
Why?
|
Patient Admission | 1 | 2007 | 1380 | 0.170 |
Why?
|
Quality Assurance, Health Care | 5 | 2008 | 2212 | 0.170 |
Why?
|
Health Care Costs | 3 | 2012 | 3208 | 0.170 |
Why?
|
Terminal Care | 5 | 2010 | 1694 | 0.170 |
Why?
|
Practice Guidelines as Topic | 9 | 2012 | 7282 | 0.170 |
Why?
|
Hospitals | 5 | 2012 | 3954 | 0.160 |
Why?
|
Sterol O-Acyltransferase | 1 | 1998 | 27 | 0.160 |
Why?
|
Physician-Patient Relations | 6 | 2015 | 3229 | 0.160 |
Why?
|
Medicare Part C | 2 | 2013 | 296 | 0.160 |
Why?
|
Psychotherapy | 1 | 2007 | 1642 | 0.150 |
Why?
|
Patient Preference | 2 | 2015 | 889 | 0.150 |
Why?
|
Cost Sharing | 2 | 2013 | 407 | 0.150 |
Why?
|
Apolipoprotein A-I | 1 | 1998 | 281 | 0.140 |
Why?
|
Health Maintenance Organizations | 2 | 2012 | 642 | 0.130 |
Why?
|
Logistic Models | 20 | 2015 | 13409 | 0.120 |
Why?
|
Medicaid | 2 | 2007 | 2737 | 0.120 |
Why?
|
Male | 56 | 2015 | 350115 | 0.120 |
Why?
|
Competitive Bidding | 1 | 2013 | 17 | 0.120 |
Why?
|
Ambulatory Care | 5 | 2007 | 2708 | 0.120 |
Why?
|
Survivors | 4 | 2009 | 2291 | 0.120 |
Why?
|
Female | 61 | 2015 | 380193 | 0.110 |
Why?
|
Humans | 86 | 2015 | 744366 | 0.110 |
Why?
|
Military Personnel | 2 | 2012 | 1133 | 0.110 |
Why?
|
Patient Satisfaction | 4 | 2015 | 3395 | 0.110 |
Why?
|
Age Factors | 10 | 2014 | 18373 | 0.110 |
Why?
|
Hospices | 2 | 2014 | 265 | 0.110 |
Why?
|
Patient Participation | 4 | 2015 | 1457 | 0.110 |
Why?
|
Patient Care Team | 2 | 2015 | 2531 | 0.110 |
Why?
|
Patient Selection | 5 | 2009 | 4216 | 0.110 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2012 | 35 | 0.110 |
Why?
|
Monte Carlo Method | 2 | 2013 | 1254 | 0.110 |
Why?
|
Contracts | 1 | 2012 | 60 | 0.110 |
Why?
|
Residence Characteristics | 4 | 2014 | 2050 | 0.100 |
Why?
|
Competitive Behavior | 1 | 2012 | 74 | 0.100 |
Why?
|
Terminally Ill | 1 | 2014 | 238 | 0.100 |
Why?
|
Early Detection of Cancer | 3 | 2015 | 3086 | 0.100 |
Why?
|
Decision Making | 6 | 2015 | 3888 | 0.100 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2011 | 29 | 0.100 |
Why?
|
Bipolar Disorder | 2 | 2013 | 5027 | 0.100 |
Why?
|
Urban Population | 2 | 2014 | 2022 | 0.100 |
Why?
|
Survival | 1 | 2011 | 163 | 0.100 |
Why?
|
Survival Analysis | 5 | 2015 | 10252 | 0.100 |
Why?
|
Longitudinal Studies | 6 | 2012 | 13991 | 0.090 |
Why?
|
Comorbidity | 7 | 2012 | 10388 | 0.090 |
Why?
|
Budgets | 1 | 2012 | 229 | 0.090 |
Why?
|
Interdisciplinary Communication | 2 | 2015 | 950 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 388 | 0.090 |
Why?
|
Data Collection | 7 | 2009 | 3339 | 0.090 |
Why?
|
Medical Records | 2 | 2014 | 1413 | 0.090 |
Why?
|
Insurance Coverage | 2 | 2013 | 1900 | 0.090 |
Why?
|
Treatment Refusal | 2 | 2011 | 421 | 0.090 |
Why?
|
Benchmarking | 2 | 2013 | 1042 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2014 | 436 | 0.090 |
Why?
|
Socioeconomic Factors | 5 | 2014 | 7785 | 0.090 |
Why?
|
Carcinoma, Small Cell | 1 | 2012 | 420 | 0.090 |
Why?
|
HIV Infections | 3 | 2012 | 16715 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1758 | 0.090 |
Why?
|
Health Services Research | 6 | 2013 | 1836 | 0.090 |
Why?
|
Middle Aged | 34 | 2015 | 213390 | 0.080 |
Why?
|
Health Care Surveys | 6 | 2015 | 2453 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 802 | 0.080 |
Why?
|
Medicare Part D | 1 | 2013 | 328 | 0.080 |
Why?
|
Cost Savings | 2 | 2012 | 925 | 0.080 |
Why?
|
Commerce | 1 | 2013 | 592 | 0.080 |
Why?
|
Models, Organizational | 1 | 2012 | 574 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2012 | 6366 | 0.080 |
Why?
|
Program Evaluation | 3 | 2013 | 2488 | 0.080 |
Why?
|
Primary Health Care | 6 | 2007 | 4557 | 0.080 |
Why?
|
Health Services Accessibility | 4 | 2014 | 5135 | 0.080 |
Why?
|
Preferred Provider Organizations | 1 | 2007 | 38 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1660 | 0.070 |
Why?
|
Formularies as Topic | 1 | 2007 | 91 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3480 | 0.070 |
Why?
|
Referral and Consultation | 5 | 2007 | 3531 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Patient Compliance | 2 | 2007 | 2684 | 0.070 |
Why?
|
Family Practice | 3 | 2005 | 516 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2012 | 971 | 0.070 |
Why?
|
Prostatic Neoplasms | 6 | 2015 | 11126 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2716 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1771 | 0.070 |
Why?
|
Odds Ratio | 4 | 2015 | 9849 | 0.070 |
Why?
|
Registries | 5 | 2013 | 8091 | 0.070 |
Why?
|
Delphi Technique | 2 | 1999 | 779 | 0.070 |
Why?
|
Cohort Studies | 14 | 2013 | 40559 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1410 | 0.060 |
Why?
|
Medical Oncology | 4 | 2007 | 2267 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2015 | 3922 | 0.060 |
Why?
|
Regression Analysis | 6 | 2010 | 6459 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 112 | 0.060 |
Why?
|
Health Facilities | 1 | 2009 | 572 | 0.060 |
Why?
|
Income | 3 | 2009 | 1913 | 0.060 |
Why?
|
Neoplasm Staging | 8 | 2015 | 11031 | 0.060 |
Why?
|
Cardiology | 3 | 2006 | 1668 | 0.060 |
Why?
|
Computer Simulation | 2 | 2013 | 6194 | 0.060 |
Why?
|
Family | 1 | 2015 | 3147 | 0.060 |
Why?
|
Patient Care | 1 | 2009 | 640 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12356 | 0.060 |
Why?
|
Communication | 3 | 2015 | 3750 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2009 | 1206 | 0.060 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 432 | 0.060 |
Why?
|
Radiation Oncology | 1 | 2009 | 555 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 941 | 0.050 |
Why?
|
Prostatectomy | 1 | 2012 | 1890 | 0.050 |
Why?
|
Employment | 1 | 2009 | 1132 | 0.050 |
Why?
|
Adult | 21 | 2015 | 214052 | 0.050 |
Why?
|
Practice Management, Medical | 1 | 2004 | 196 | 0.050 |
Why?
|
Population Surveillance | 3 | 2013 | 2616 | 0.050 |
Why?
|
Trust | 1 | 2007 | 505 | 0.050 |
Why?
|
Minnesota | 4 | 2004 | 344 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1378 | 0.050 |
Why?
|
Gatekeeping | 1 | 2001 | 45 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1209 | 0.050 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12244 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2014 | 4851 | 0.050 |
Why?
|
Mastectomy, Segmental | 2 | 2010 | 956 | 0.050 |
Why?
|
Diabetes Mellitus | 3 | 2004 | 5749 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2278 | 0.050 |
Why?
|
Insurance, Health | 2 | 2013 | 2494 | 0.050 |
Why?
|
Hospital Costs | 1 | 2007 | 985 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6539 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2007 | 783 | 0.050 |
Why?
|
Human Experimentation | 1 | 2001 | 127 | 0.050 |
Why?
|
Aftercare | 1 | 2007 | 870 | 0.050 |
Why?
|
Survival Rate | 2 | 2012 | 12788 | 0.050 |
Why?
|
Androgen Antagonists | 1 | 2009 | 1377 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2015 | 63107 | 0.050 |
Why?
|
Tobacco Industry | 1 | 2002 | 126 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2010 | 5321 | 0.050 |
Why?
|
Utilization Review | 2 | 2001 | 392 | 0.050 |
Why?
|
Birth Rate | 1 | 2001 | 170 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3508 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5388 | 0.040 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3057 | 0.040 |
Why?
|
Self Care | 1 | 2004 | 786 | 0.040 |
Why?
|
Medicine | 3 | 2010 | 946 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2419 | 0.040 |
Why?
|
Prospective Studies | 6 | 2015 | 53290 | 0.040 |
Why?
|
Health Services | 1 | 2004 | 758 | 0.040 |
Why?
|
Cholesterol Esters | 1 | 1998 | 73 | 0.040 |
Why?
|
Normal Distribution | 1 | 1999 | 280 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7914 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2200 | 0.040 |
Why?
|
Circular Dichroism | 1 | 1998 | 354 | 0.040 |
Why?
|
Anticholesteremic Agents | 2 | 2002 | 979 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2010 | 3047 | 0.040 |
Why?
|
Specialization | 2 | 2001 | 776 | 0.040 |
Why?
|
Mammography | 2 | 2006 | 2475 | 0.040 |
Why?
|
Tamoxifen | 1 | 2002 | 981 | 0.040 |
Why?
|
Cost Control | 2 | 2012 | 624 | 0.040 |
Why?
|
Inpatients | 1 | 2009 | 2518 | 0.040 |
Why?
|
Massachusetts | 6 | 2012 | 8662 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 604 | 0.040 |
Why?
|
Epitope Mapping | 1 | 1998 | 311 | 0.040 |
Why?
|
Incidence | 2 | 2012 | 20952 | 0.040 |
Why?
|
Quality Improvement | 1 | 2012 | 3749 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2010 | 13693 | 0.040 |
Why?
|
Cholesterol | 2 | 2004 | 2919 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 1872 | 0.040 |
Why?
|
Solubility | 1 | 1998 | 1088 | 0.030 |
Why?
|
Expert Testimony | 1 | 1999 | 356 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 798 | 0.030 |
Why?
|
Retrospective Studies | 12 | 2015 | 77460 | 0.030 |
Why?
|
Interviews as Topic | 3 | 2013 | 2539 | 0.030 |
Why?
|
Databases, Factual | 3 | 2011 | 7730 | 0.030 |
Why?
|
Electrocardiography | 2 | 2006 | 6442 | 0.030 |
Why?
|
Markov Chains | 1 | 1999 | 969 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2838 | 0.030 |
Why?
|
California | 2 | 2014 | 1402 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1247 | 0.030 |
Why?
|
Physician's Role | 1 | 2001 | 943 | 0.030 |
Why?
|
Phospholipids | 1 | 1998 | 784 | 0.030 |
Why?
|
Iowa | 1 | 2014 | 101 | 0.030 |
Why?
|
Alabama | 1 | 2014 | 98 | 0.030 |
Why?
|
Risk Factors | 5 | 2014 | 72296 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5181 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 1998 | 638 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2002 | 1524 | 0.030 |
Why?
|
Smoking | 3 | 2010 | 8987 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 315 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14723 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3841 | 0.030 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 68 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39052 | 0.030 |
Why?
|
Physicians | 2 | 2008 | 4567 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2575 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4293 | 0.030 |
Why?
|
Veterans Health | 1 | 2014 | 216 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1998 | 3130 | 0.030 |
Why?
|
Health Status | 1 | 2005 | 4034 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 977 | 0.030 |
Why?
|
Costs and Cost Analysis | 2 | 2012 | 1680 | 0.030 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2012 | 94 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1998 | 3702 | 0.030 |
Why?
|
Time Factors | 5 | 2015 | 40075 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2012 | 299 | 0.020 |
Why?
|
Mental Health | 1 | 2005 | 3010 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2012 | 284 | 0.020 |
Why?
|
Young Adult | 6 | 2015 | 56429 | 0.020 |
Why?
|
Rural Population | 1 | 2001 | 2207 | 0.020 |
Why?
|
Office Visits | 2 | 2007 | 598 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 29786 | 0.020 |
Why?
|
Prognosis | 4 | 2015 | 29060 | 0.020 |
Why?
|
Drug Utilization | 2 | 2007 | 1183 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 4010 | 0.020 |
Why?
|
Viral Load | 2 | 2012 | 3300 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2002 | 2071 | 0.020 |
Why?
|
Awareness | 1 | 2014 | 640 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2015 | 1179 | 0.020 |
Why?
|
Comprehension | 1 | 2015 | 610 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4687 | 0.020 |
Why?
|
Intensive Care Units | 3 | 2010 | 3680 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2649 | 0.020 |
Why?
|
Health Personnel | 1 | 2002 | 3219 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.020 |
Why?
|
Hospitalization | 4 | 2013 | 10259 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2009 | 288 | 0.020 |
Why?
|
Models, Economic | 1 | 2012 | 712 | 0.020 |
Why?
|
Private Sector | 1 | 2011 | 392 | 0.020 |
Why?
|
Mastectomy | 2 | 2010 | 1793 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
Pneumonia | 2 | 2010 | 2133 | 0.020 |
Why?
|
Biostatistics | 1 | 2009 | 161 | 0.020 |
Why?
|
Depression | 1 | 2007 | 7759 | 0.020 |
Why?
|
Incidental Findings | 1 | 2012 | 689 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 2887 | 0.020 |
Why?
|
Demography | 2 | 2002 | 1655 | 0.020 |
Why?
|
Financing, Personal | 1 | 2009 | 308 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 326 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2006 | 1873 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1316 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2560 | 0.020 |
Why?
|
Protein Binding | 1 | 1998 | 9384 | 0.020 |
Why?
|
Algorithms | 3 | 2014 | 13882 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2166 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3270 | 0.020 |
Why?
|
Community Health Services | 1 | 2009 | 650 | 0.020 |
Why?
|
Health Care Reform | 1 | 2013 | 1261 | 0.010 |
Why?
|
Sex Factors | 3 | 2002 | 10400 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1999 | 19905 | 0.010 |
Why?
|
Internal Medicine | 2 | 2002 | 1009 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2010 | 719 | 0.010 |
Why?
|
Health Care Sector | 1 | 2005 | 194 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 607 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11525 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2007 | 695 | 0.010 |
Why?
|
Radiotherapy | 1 | 2010 | 1533 | 0.010 |
Why?
|
Insurance Claim Review | 1 | 2007 | 720 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 2002 | 2288 | 0.010 |
Why?
|
Quality of Life | 1 | 2003 | 12802 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 3914 | 0.010 |
Why?
|
Ethics | 1 | 2001 | 94 | 0.010 |
Why?
|
Medication Adherence | 1 | 2013 | 2063 | 0.010 |
Why?
|
Role | 1 | 2002 | 175 | 0.010 |
Why?
|
Axilla | 1 | 2003 | 597 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
Risk Assessment | 2 | 2002 | 23336 | 0.010 |
Why?
|
American Heart Association | 1 | 2006 | 1057 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2001 | 288 | 0.010 |
Why?
|
Insurance Claim Reporting | 1 | 2001 | 163 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 657 | 0.010 |
Why?
|
Cardiology Service, Hospital | 1 | 2002 | 246 | 0.010 |
Why?
|
Ethics Committees, Research | 1 | 2001 | 194 | 0.010 |
Why?
|
Florida | 1 | 2001 | 435 | 0.010 |
Why?
|
Taxes | 1 | 2002 | 221 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2760 | 0.010 |
Why?
|
State Government | 1 | 2002 | 372 | 0.010 |
Why?
|
Mass Screening | 2 | 2005 | 5253 | 0.010 |
Why?
|
Research Design | 2 | 2005 | 5984 | 0.010 |
Why?
|
General Surgery | 1 | 2010 | 1636 | 0.010 |
Why?
|
New England | 1 | 2001 | 1022 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 85779 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7658 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2001 | 692 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2003 | 1262 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 1956 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 948 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3611 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1167 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8642 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9312 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4255 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2006 | 2162 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13286 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1240 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1530 | 0.010 |
Why?
|
Life Expectancy | 1 | 2002 | 1184 | 0.010 |
Why?
|
Software | 1 | 2009 | 4441 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 7023 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6939 | 0.010 |
Why?
|
Schizophrenia | 1 | 2013 | 6882 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2190 | 0.010 |
Why?
|
Health Behavior | 1 | 2005 | 2635 | 0.010 |
Why?
|
Educational Status | 1 | 2001 | 2540 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2951 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15535 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2001 | 1637 | 0.010 |
Why?
|
Mental Health Services | 1 | 2002 | 1644 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9145 | 0.010 |
Why?
|
Aspirin | 1 | 2001 | 3283 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2005 | 21748 | 0.000 |
Why?
|
Cardiovascular Diseases | 2 | 2002 | 15160 | 0.000 |
Why?
|
Heart Failure | 1 | 2010 | 10895 | 0.000 |
Why?
|
Aging | 1 | 2003 | 8664 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 25039 | 0.000 |
Why?
|